Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study Dagoberto Serpa-DíazCarlos A. Llanos-FlorezMaria A. Alzate-Vinasco Original Research Open access 30 April 2024
Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis Rachel S. NewsonVictoria DivinoJulie E. Mount Original Research Open access 29 April 2024
Podcast on the IWGDF 2023 Guidelines on the Prevention of Foot Ulcers in Persons with Diabetes Sicco A. BusJaap J. Van Netten Commentary Open access 26 April 2024
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy Francesco Saverio MenniniPaolo SciattellaUgo Trama Original Research Open access 26 April 2024
Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review Omnia Azmy NabehAlaa AmrSoha Aly Elmorsy Review Open access 26 April 2024
Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump Terri JerkinsKatherine StockhamDavid S. H. Bell Case Report Open access 24 April 2024
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study) Masahiro FukudaIchiro Sakumaon behalf of the J-SELECT study investigators Original Research Open access 24 April 2024
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol Peter NovodvorskýLenka ThiemeMartin Haluzík Study Protocol Open access 24 April 2024
Correction to: Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD Giuseppina GuarinoFelice StrolloSandro Gentile Correction Open access 22 April 2024
Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years Daniel TajdarDagmar LühmannIngmar Schäfer Original Research Open access 20 April 2024
Psychosocial Self-efficacy and its Association with Selected Potential Factors Among Adults with Type 1 Diabetes: A Cross-Sectional Survey Study Divya Anna StephenAnna NordinJan Nilsson Original Research Open access 20 April 2024
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study Pierre GourdyPatrice DarmonAlfred Penfornis Original Research Open access 20 April 2024
Real-World Effectiveness of the Gla-300 + Cap + App Program in Adult Users Living with Type 2 Diabetes in Taiwan Chih-Yuan WangFang L. ZhouJung-Fu Chen Original Research Open access 20 April 2024
Correction to: Use of IDegLira to Intensify, Simplify, and Increase Appropriateness of Type 2 Diabetes Therapy: A Real-Life Experience Isabella RomanoRosalia Serra Correction Open access 18 April 2024
Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia–Pacific Region Roger ChenAzizul Hasan AamirRoopa Mehta Review Open access 16 April 2024
Neutrophil Extracellular Traps (NETs) Are Associated with Type 2 Diabetes and Diabetic Foot Ulcer Related Amputation: A Prospective Cohort Study Irshat IbrahimYilimire NuermaimaitiYuanquan Wu Original Research Open access 15 April 2024
Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study Chiara Di LoretoRoberta CellenoPaola Del Sindaco Original Research Open access 11 April 2024
Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study Björn EliassonElin Allansson KjölhedeKatarina Eeg-Olofsson Original Research Open access 10 April 2024
Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus Yujie ZhangXiao YinXindao Yin Original Research Open access 05 April 2024 Pages: 1215 - 1229
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review Samuel SeiduVicki AlabrabaJohn P. H. Wilding Review Open access 05 April 2024 Pages: 1099 - 1124
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial Lori M. Laffel Summary of Research Open access 05 April 2024 Pages: 893 - 896
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study) Tamiko TamanahaHisashi MakinoKiminori Hosoda Study Protocol Open access 04 April 2024 Pages: 1245 - 1254
An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D) Kevin M. PantaloneBruce RogenBartolome Burguera Original Research Open access 04 April 2024 Pages: 1201 - 1214
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review Janet B. McGillIrl B. HirschJames R. Gavin III Review Open access 04 April 2024 Pages: 1085 - 1098
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes Robert M. GutgesellRubén NogueirasTimo D. Müller Review Open access 04 April 2024 Pages: 1069 - 1084
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study Akiko TakahashiManabu IshiiMakoto Kunisaki Original Research Open access 30 March 2024 Pages: 1187 - 1199
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity Klara R. KleinTrine J. Abrahamsenon behalf of the N3C Consortium Original Research Open access 27 March 2024 Pages: 1169 - 1186
Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes Anu GuptaAlpesh GoyalYashdeep Gupta Original Research Open access 23 March 2024 Pages: 1155 - 1168
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis Esteban J. GimenoMette BøgelundDomingo Orozco-Beltran Review Open access 23 March 2024 Pages: 1047 - 1067
The Why, What and Where Podcast on the Updated 2023 IWGDF Guideline on Offloading Treatments for Diabetes-Related Foot Ulcers Sicco A. BusPeter A. Lazzarini Commentary Open access 23 March 2024
Podcast on How to Classify Foot Ulcers in People with Diabetes (2023 Update of the IWGDF Guidelines on Classification) Matilde Monteiro-SoaresFran Game Commentary Open access 21 March 2024
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial Xiaxuan ZhuLi XiaRui Wei Study Protocol Open access 18 March 2024 Pages: 1231 - 1244
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study Sakiko TeruiMari IgariJun Shirakawa Original Research Open access 18 March 2024 Pages: 1139 - 1153
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups Yan BiSong LuLinong Ji Original Research Open access 18 March 2024 Pages: 1125 - 1137
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design Kristin CastorinoBeatrice OsumiliCarolina Piras de Oliveira Review Open access 18 March 2024 Pages: 929 - 1045
The Implication of Diabetes-Specialized Nurses in Aiming for the Better Treatment and Management of Patients with Diabetes Mellitus: A Brief Narrative Review Yefang ZhuHongmei ZhangHong Lei Review Open access 12 March 2024 Pages: 917 - 927
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel Adam G. TabakPeter KemplerBoris Mankovsky Review Open access 12 March 2024 Pages: 897 - 915
Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT) Weimin WangXiangyun ChangDalong Zhu Original Research Open access 05 March 2024 Pages: 725 - 739
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study Sharmistha Roy ChowdhuryFethi SadoukiStephen C. Bain Brief Report Open access 01 March 2024 Pages: 869 - 881
Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study Meredith HoogJuan M. MaldonadoManige Konig Original Research Open access 01 March 2024 Pages: 855 - 867
Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study Amy L. McKenzieShaminie J. Athinarayanan Original Research Open access 29 February 2024 Pages: 843 - 853
Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model Hiroaki IijimaHidetoshi ShimizuTakashi Kadowaki Publisher Correction Open access 29 February 2024 Pages: 779 - 780
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis Jonathan Y. M. LaiDavid R. RileyUazman Alam Original Research Open access 24 February 2024 Pages: 833 - 842
Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist Xiaosu MaRong LiuKyle W. Sloop Original Research Open access 24 February 2024 Pages: 819 - 832
Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study Kazuo HaraTetsuaki HiraseRyo Takemura Original Research Open access 24 February 2024 Pages: 801 - 817
Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Yuying CuiJinming YaoLin Liao Original Research Open access 24 February 2024 Pages: 781 - 799
Personalized Versus Non-personalized Nutritional Recommendations/Interventions for Type 2 Diabetes Mellitus Remission: A Narrative Review Ana T. Arias-MarroquínFabiola M. Del Razo-OlveraCarlos A. Aguilar-Salinas Review Open access 20 February 2024 Pages: 749 - 761
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan Daisuke YabeMunehide MatsuhisaYasuo Terauchi Original Research Open access 16 February 2024 Pages: 705 - 723
Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review Stavroula A. PaschouKleoniki I. AthanasiadouNikolaos Papanas Review Open access 16 February 2024 Pages: 741 - 748
Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in Japan Junko SatoKenichi NakajimaHirotaka Watada Study Protocol Open access 15 February 2024 Pages: 883 - 892